Literature DB >> 16307654

Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey--Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002.

M A Gupta1, A K Gupta, S J Chen, A M Johnson.   

Abstract

BACKGROUND: Psychogenic factors have been considered to be important in the exacerbation and possibly the onset of rosacea. However, there are very few studies that have reported conclusive findings.
OBJECTIVES: To examine the association between rosacea and major depressive disease, a common and usually treatable psychiatric disorder.
METHODS: Data from 1995 to 2002, collected by the National Ambulatory Medical Care Survey and the outpatient component of the National Hospital Ambulatory Care Survey, which are both nationally representative surveys of healthcare visits in the U.S.A., were studied. The basic sampling unit in both surveys is the patient visit or encounter. A "Rosacea" variable was created by grouping all rosacea (ICD-9-CM code 695.3) visits and a "Depression" variable was created by grouping the patient visits related to major depressive disorder (ICD-9-CM codes 296.2, 296.3 and 311). As alcohol abuse has been implicated in rosacea, and alcohol can confound symptoms of depression, an "Alcohol" variable was created by grouping all ICD-9-CM codes related to alcohol dependence and abuse (codes 303, 303.0, 303.9 and 305.0). All analyses were conducted using the Complex Samples module of SPSS version 13, to account for the multistage probability sampling design used to collect the data.
RESULTS: The weighted data were representative of over 608 million dermatology visits between 1995 and 2002. Logistic regression analysis using "Rosacea" as the dependent variable and age, sex, "Alcohol" and "Depression" as independent variables revealed that the odds ratio for depressive disease in the rosacea group was 4.81 (95% confidence interval 1.39-16.62). The association between "Alcohol" and "Rosacea" was not significant.
CONCLUSIONS: The comorbidity between major depressive disease and rosacea may have important clinical implications. Alcohol abuse does not appear to play a significant role in this association.

Entities:  

Mesh:

Year:  2005        PMID: 16307654     DOI: 10.1111/j.1365-2133.2005.06895.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

1.  Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea.

Authors:  Lisa A Raedler
Journal:  Am Health Drug Benefits       Date:  2015-03

Review 2.  [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies].

Authors:  A Sobottka; P Lehmann
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

3.  Alcohol intake and risk of rosacea in US women.

Authors:  Suyun Li; Eunyoung Cho; Aaron M Drucker; Abrar A Qureshi; Wen-Qing Li
Journal:  J Am Acad Dermatol       Date:  2017-04-20       Impact factor: 11.527

4.  Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life.

Authors:  Tu T Huynh
Journal:  Am Health Drug Benefits       Date:  2013-07

Review 5.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

6.  Update on the management of rosacea.

Authors:  Allison P Weinkle; Vladyslava Doktor; Jason Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-07

7.  Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China.

Authors:  Mengting Chen; Zhili Deng; Yingxue Huang; Ji Li
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 4.157

8.  A Multi-Center Structural Equation Modeling Approach to Investigate Interpersonal Violence Screening for Public Health Promotion.

Authors:  Lan Jiang; Melissa A Sutherland; M Katherine Hutchinson; Bing Si
Journal:  Front Public Health       Date:  2021-06-11

9.  Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.

Authors:  A M Layton; M Schaller; B Homey; M A Hofmann; A P Bewley; P Lehmann; C Nohlgård; D B Sarwer; N Kerrouche; Y M Ma
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-09-28       Impact factor: 6.166

Review 10.  Rosacea: Epidemiology, pathogenesis, and treatment.

Authors:  Barbara M Rainer; Sewon Kang; Anna L Chien
Journal:  Dermatoendocrinol       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.